Pietro Randine

Pietro Randine

Auto-generated profile, based on publicly available information

Pietro Randine

UiT The Arctic University of Norway, Tromsø, Norway

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
Dillys LarbiDillys Larbi
Dillys Larbi
PRPietro Randine
Pietro Randine
EÅEirik Årsand
Eirik Årsand
KAKonstantinos Antypas
Konstantinos Antypas
MBMeghan Bradway
Meghan Bradway
EGElia Gabarron
Elia Gabarron
Background: There is growing evidence that apps and digital interventions have a positive impact on diabetes self-management. Standard self-management for patients with diabetes could therefore be supplemented by apps and digital interventions to increase patients’ skills. Several initiatives, models, and frameworks suggest how health apps and digital interventions could be evaluated, but there are few standards for this. And although there are many methods for evaluating apps and digital interventions, a more specific approach might be needed for assessing digital diabetes self-management interventions. Objective: This review aims to identify which methods and criteria are used to evaluate apps and digital interventions for diabetes self-management, and to describe how patients were involved in these evaluations. Methods: We searched CINAHL, EMBASE, MEDLINE, and Web of Science for articles published from 2015 that referred to the evaluation of apps and digital interventions for diabetes self-management and involved patients in the evaluation. We then conducted a narrative qualitative synthesis of the findings, structured around the included studies’ quality, methods of evaluation, and evaluation criteria. Results: Of 1681 articles identified, 31 fulfilled the inclusion criteria. A total of 7 articles were considered of high confidence in the evidence. Apps were the most commonly used platform for diabetes self-management (18/31, 58%), and type 2 diabetes (T2D) was the targeted health condition most studies focused on (12/31, 38%). Questionnaires, interviews, and user-group meetings were the most common methods of evaluation. Furthermore, the most evaluated criteria for apps and digital diabetes self-management interventions were cognitive impact, clinical impact, and usability. Feasibility and security and privacy were not evaluated by studies considered of high confidence in the evidence. Conclusions: There were few studies with high confidence in the evidence that involved patients in the evaluation of apps and digital interventions for diabetes self-management. Additional evaluation criteria, such as sustainability and interoperability, should be focused on more in future studies to provide a better understanding of the effects and potential of apps and digital interventions for diabetes self-management.

29 April 2022 in International Journal of Medical Informatics
Verified
Journal Article
Open access
PRPietro Randine
Pietro Randine
ASAakash Sharma
Aakash Sharma
GHGunnar Hartvigsen
Gunnar Hartvigsen
HJHåvard D. Johansen
Håvard D. Johansen
EÅEirik Årsand
Eirik Årsand
Medical consultations are often critical meetings between patients and health personnel to provide treatment, health-management advice, and exchange of information, especially for people living with chronic diseases. The adoption of patient-operated Information and Communication Technologies (ICTs) allows the patients to actively participate in their consultation and treatment. The consultation can be divided into three different phases: before, during, and after the meeting. The difference is identified by the activities in preparation (before), the meeting, conducted either physically or in other forms of non-face-to-face interaction (during), and the follow-up activities after the meeting (after). Consultations can be supported by various ICT-based interventions, often referred to as eHealth, mHealth, telehealth, or telemedicine. Nevertheless, the use of ICTs in healthcare settings is often accompanied by security and privacy challenges due to the sensitive nature of health information and the regulatory requirements associated with storing and processing sensitive information. This scoping review aims to map the existing knowledge and identify gaps in research about ICT-based interventions for chronic diseases consultations. The review objective is guided by three research questions: (1) which ICTs are used by people with chronic diseases, health personnel, and others before, during, and after consultations; (2) which type of information is managed by these ICTs; and (3) how are security and privacy issues addressed? We performed a literature search in ACM, IEEE, PubMed, Scopus, and Web of Science and included primary studies published between January 2015 and June 2020 that used ICT before, during, and/or after a consultation for chronic diseases. This review presents and discusses the findings from the included publications structured around the three research questions. Twenty-four studies met the inclusion criteria. Only five studies reported the use of ICTs in all three phases: before, during, and after consultations. The main ICTs identified were smartphone applications, web-based portals, cloud-based infrastructures, and electronic health record systems. Different devices like sensors and wearable devices were used in 23 studies to gather diverse information. Regarding the type of information managed by these ICTs, we identified nine categories: physiological data, treatment information, medical history, consultation media like images or videos, laboratory results, reminders, lifestyle parameters, symptoms, and patient identification. Security issues were addressed in 20 studies, while only eight of the included studies addressed privacy issues. This scoping review highlights the potential for a new model of consultation for patients with chronic diseases. Furthermore, it emphasizes the possibilities for consultations besides physical and remote meetings. The scoping review also revealed a narrow focus on security and privacy. Security issues were more likely to be mentioned in the included publications, although with limited details. Future research should focus more on security and privacy due to the increasing amount of sensitive information gathered and used for consultations.

10 February 2020 in JMIR Research Protocols
Verified
Journal Article
Open access
MBMeghan Bradway
Meghan Bradway
AGAlain Giordanengo
Alain Giordanengo
RJRagnar Joakimsen
Ragnar Joakimsen
AHAnne Helen Hansen
Anne Helen Hansen
AGAstrid Grøttland
Astrid Grøttland
EÅEirik Årsand
Eirik Årsand
Background: There is rising demand for health care’s limited resources. Mobile health (mHealth) could be a solution, especially for those with chronic illnesses such as diabetes. mHealth can increases patients’ options to self-manage their health, improving their health knowledge, engagement, and capacity to contribute to their own care decisions. However, there are few solutions for sharing and presenting patients’ mHealth data with health care providers (HCPs) in a mutually understandable way, which limits the potential of shared decision making. Objective: Through a six-month mixed method feasibility study in Norway, we aim to explore the impacts that a system for sharing patient-gathered data from mHealth devices has on patients and HCPs during diabetes consultations. Methods: Patients with diabetes will be recruited through their HCPs. Participants will use the Diabetes Diary mobile phone app to register and review diabetes self-management data and share these data during diabetes consultations using the FullFlow data-sharing system. The primary outcome is the feasibility of the system, which includes HCP impressions and expectations (prestudy survey), usability (System Usability Scale), functionalities used and data shared during consultations, and study-end focus group meetings. Secondary outcomes include a change in the therapeutic relationship, patient empowerment and wellness, health parameters (HbA1c and blood pressure), and the patients’ own app-registered health measures (blood glucose, medication, physical activity, diet, and weight). We will compare measures taken at baseline and at six months, as well as data continuously gathered from the app. Analysis will aim to explain which measures have changed and how and why they have changed during the intervention. Results: The Full Flow project is funded for 2016 to 2020 by the Research Council of Norway (number 247974/O70). We approached 14 general practitioner clinics (expecting to recruit 1-2 general practitioners per clinic) and two hospitals (expecting to recruit 2-3 nurses per hospital). By recruiting through the HCPs, we expect to recruit 74 patients with type 2 and 33 patients with type 1 diabetes. Between November 2018 and July 2019, we recruited eight patients and 15 HCPs. During 2020, we aim to analyze and publish the results of the collected data from our patient and HCP participants. Conclusions: We expect to better understand what is needed to be able to share data. This includes potential benefits that sharing patient-gathered data during consultations will have on patients and HCPs, both individually and together. By measuring these impacts, we will be able to present the possibilities and challenges related to a system for sharing mHealth data for future interventions and practice. Results will also demonstrate what needs to be done to make this collaboration between HCPs and patients successful and subsequently further improve patients’ health and engagement in their care.

28 March 2025 in Journal of Diabetes Science and Technology
Verified
Journal Article
Open access
PRPietro Randine
Pietro Randine
MWMiriam Kopperstad Wolff
Miriam Kopperstad Wolff
MPMatthias Pocs
Matthias Pocs
ICIan R. O. Connell
Ian R. O. Connell
JCJoseph A. Cafazzo
Joseph A. Cafazzo
EÅEirik Årsand
Eirik Årsand
Background: In today’s data-driven era, openness promotes transparency and accessibility, particularly in health initiatives like the European Health Data Space. Diabetes management relies on real-time data from medical devices, such as continuous glucose monitors (CGMs), insulin pumps, and hybrid closed-loop systems. These devices provide critical insights for treatment adjustments, making real-time data access essential. Methods: This article explores real-time data access for third-party applications, focusing on primary (treatment) and secondary (research) use. We examine how application programming interfaces (APIs) enable secure data retrieval and assess the impact of terms of service and copyright law on patient-driven innovation in open-source communities. Our research evaluates diabetes medical devices and software solutions in Norway, assessing their real-time data access and API functionalities. In addition, we analyze legal frameworks governing these technologies, focusing on challenges faced by open-source solutions. Based on our findings, we propose an interoperability model to improve data accessibility while ensuring security and transparency. Results: Findings reveal seven diabetes devices and nine regulated software solutions, with only one offering a publicly accessible API. This emphasizes a significant gap in real-time data access. Comparisons between vendor-specific and open-source software expose interoperability and accessibility challenges. While Do-It-Yourself (DIY) solutions foster innovation, they face technical and legal barriers. Conclusion: Real-time diabetes management presents security, transparency, and access challenges. Regulatory decisions are needed to implement an interoperability model. The lack of real-time data access highlights the necessity of publicly accessible APIs that prioritize transparency, accessibility, and patient-driven innovation—marking a shift from today’s constrained diabetes management landscape.

13 November 2023 in Journal of Diabetes Science and Technology
Verified
Journal Article
Open access
PRPietro Randine
Pietro Randine
MPMatthias Pocs
Matthias Pocs
JCJohn Graham Cooper
John Graham Cooper
DTDimitrios Tsolovos
Dimitrios Tsolovos
MMMiroslav Muzny
Miroslav Muzny
EÅEirik Årsand
Eirik Årsand
Background: Individuals with diabetes rely on medical equipment (eg, continuous glucose monitoring (CGM), hybrid closed-loop systems) and mobile applications to manage their condition, providing valuable data to health care providers. Data sharing from this equipment is regulated via Terms of Service (ToS) and Privacy Policy documents. The introduction of the Medical Devices Regulation (MDR) and In Vitro Diagnostic Medical Devices Regulation (IVDR) in the European Union has established updated rules for medical devices, including software. Objective: This study examines how data sharing is regulated by the ToS and Privacy Policy documents of approved diabetes medical equipment and associated software. It focuses on the equipment approved by the Norwegian Regional Health Authorities. Methods: A document analysis was conducted on the ToS and Privacy Policy documents of diabetes medical equipment and software applications approved in Norway. Results: The analysis identified 11 medical equipment and 12 software applications used for diabetes data transfer and analysis in Norway. Only 3 medical equipment (OmniPod Dash, Accu-Chek Insight, and Accu-Chek Solo) were registered in the European Database on Medical Devices (EUDAMED) database, whereas none of their respective software applications were registered. Compliance with General Data Protection Regulation (GDPR) security requirements varied, with some software relying on adequacy decisions (8/12), whereas others did not (4/12). Conclusions: The study highlights the dominance of non-European Economic Area (EEA) companies in medical device technology development. It also identifies the lack of registration for medical equipment and software in the EUDAMED database, which is currently not mandatory. These findings underscore the need for further attention to ensure regulatory compliance and improve data-sharing practices in the context of diabetes management.

29 January 2026 in Digital Health
Verified
Journal Article
Open access
Dillys LarbiDillys Larbi
Dillys Larbi
PZPaolo Zanaboni
Paolo Zanaboni
EÅEirik Årsand
Eirik Årsand
PRPietro Randine
Pietro Randine
MTMarianne Vibeke Trondsen
Marianne Vibeke Trondsen
EGElia Gabarron
Elia Gabarron
Background: FysBot is a ChatGPT-based mobile app developed to promote physical activity among adults living with obesity. This pilot study aimed to evaluate the feasibility and usability of FysBot. Methods: A 6-week single-arm pilot study was conducted in which patients from an obesity rehabilitation clinic in Norway used FysBot. This pilot study employed an explanatory sequential mixed-methods design combining questionnaires and post-intervention interviews. Participants completed questionnaires at baseline and weeks 2, 4, and 6, assessing leisure-time physical activity (Godin Leisure-Time Exercise Questionnaire (GODIN)), motivation (Behavioral Regulation in Exercise Questionnaire-2 and relative autonomy index (RAI)), Self-Efficacy for Exercise (SEE), and System Usability Scale (SUS). Semi-structured interviews were conducted to explore user experiences further. Quantitative data were analyzed descriptively, with multiple imputations for missing data, while qualitative data were analyzed thematically. Results: Fifty-three participants were eligible, 36 completed baseline, and 17 completed the final follow-up. App engagement declined steadily, with most participants ceasing use after week 2. The mean SUS score was 51.3, indicating below-average usability. The median of self-reported leisure-time physical activity (GODIN: 34–40) and overall motivation (RAI: 8.3–9.8) showed small, non-significant increases, while identified regulation increased significantly (2.8–3.3; p = 0.04) and SEE decreased (58–49). Qualitative findings supported these results, showing that participants valued the chatbot's motivational potential but experienced technical problems and limited personalization. Conclusions: This study offers insight into the potential of a ChatGPT-based physical activity app for adults living with obesity and highlights key areas for refinement. Future iterations should incorporate user-requested features through iterative co-design, with enhanced personalization and guidance to improve relevance and engagement.